Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast Surgery

Sponsor
Albert Einstein Healthcare Network (Other)
Overall Status
Recruiting
CT.gov ID
NCT04554316
Collaborator
(none)
126
2
2
29.4
63
2.1

Study Details

Study Description

Brief Summary

All patients undergoing breast biopsy, lumpectomy, needle-localization-guided breast biopsy, and mastectomy at Einstein Medical Center Philadelphia, Einstein Medical Center Montgomery, Center One, or Einstein Elkins Park will be offered participation into the study. Patients who have documented allergies to adhesive or tape, patients taking chronic steroids, and patients with documented connective tissue, skin, or healing disorders will be excluded from the study. Risks and benefits of the study as well as risks and benefits of the procedure will be discussed with the patient by one of the investigators. If the patient elects to participate in the study, they will be assigned to incisional dressing at the time of operation with either in-line or perpendicular placement of Steri-Strips based on the patient's computer-generated randomization assignment. The patient's chart will be reviewed to determine the patient's age and comorbid conditions including obesity (pre-operative BMI), diabetes mellitus, use of anti-platelet or anticoagulant medication, or smoking. This information will be utilized to ensure that our study groups are similar in baseline demographics and pre-existing conditions. Additionally, the primary medical reason for needing breast surgery will be reviewed as well as treatment with pre-operative or post-operative chemotherapy or radiation therapy to the breast. Steri-Strips will not be removed and will be allowed to fall off naturally. At regularly scheduled 30-day and 90-day follow-up appointments, pictures will be taken of the incisional area. These photographs will be reviewed by a blinded, independent surgeon who will grade each incision according to the modified Hollander Cosmesis Scale. Statistical analysis with t-testing of the means and chi-squared testing of dichotomous variables will be performed to determine significance of the findings.

Condition or Disease Intervention/Treatment Phase
  • Device: Steri-strip
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
126 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast Surgery
Actual Study Start Date :
Nov 1, 2020
Anticipated Primary Completion Date :
Jan 15, 2023
Anticipated Study Completion Date :
Apr 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Parallel placement

Steri-strips will be placed in-line (parallel) with the surgical incision.

Device: Steri-strip
Steri-Strips (3M Health Care, St. Paul, Minn) are a commonly used means of covering surgical incisions following many operations. Use of adhesive surgical tape over incisions maintains epidermal approximation in primary skin closure while limiting exposure to the environment, theoretically improving cosmesis and limiting risk of infection.

Active Comparator: Perpendicular placement

Steri-strips will be placed perpendicular to the surgical incision.

Device: Steri-strip
Steri-Strips (3M Health Care, St. Paul, Minn) are a commonly used means of covering surgical incisions following many operations. Use of adhesive surgical tape over incisions maintains epidermal approximation in primary skin closure while limiting exposure to the environment, theoretically improving cosmesis and limiting risk of infection.

Outcome Measures

Primary Outcome Measures

  1. Cosmesis score 30 days [30 days]

    Hollander cosmesis scale (0-6, 6 being best cosmetic grade) grade of scar appearance at 30 days

  2. Cosmesis score 90 days [90 days]

    Hollander cosmesis scale (0-6, 6 being best cosmetic grade) grade of scar appearance at 90 days

Secondary Outcome Measures

  1. Surgical site infection [90 days]

    Presence or absence of surgical site infection

  2. Wound dehiscence [90 days]

    Presence or absence of wound dehiscence

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All adult patients undergoing breast biopsy, lumpectomy, needle-localization-guided breast biopsy, and mastectomy at Einstein Medical Center Philadelphia, Einstein Medical Center Montgomery, Center One, or Einstein Medical Center Elkins Park will be offered participation into the study.
Exclusion Criteria:
  • Patients who have documented allergies to adhesive or tape, patients taking chronic steroids, and patients with documented connective tissue, skin, or healing disorders

  • members of vulnerable populations such as adults who are unable to consent, individuals who are not yet adults, pregnant women, or prisoners

Contacts and Locations

Locations

Site City State Country Postal Code
1 Albert Einstein Medical Center Montgomery East Norriton Pennsylvania United States 19403
2 Albert Einstein Medical Center Philadelphia Pennsylvania United States 19141

Sponsors and Collaborators

  • Albert Einstein Healthcare Network

Investigators

  • Principal Investigator: Candace L Ward, MD, MPH, Albert Einstein Medical Center Phialdelphia

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Candace Ward, Principal Investigator, Albert Einstein Healthcare Network
ClinicalTrials.gov Identifier:
NCT04554316
Other Study ID Numbers:
  • IRB-2019-118
First Posted:
Sep 18, 2020
Last Update Posted:
Jan 28, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Candace Ward, Principal Investigator, Albert Einstein Healthcare Network
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 28, 2022